Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.67B |
| 2 |
Snowflake
SNOW
|
+$1.03B |
| 3 |
Shopify
SHOP
|
+$940M |
| 4 |
TJX Companies
TJX
|
+$933M |
| 5 |
TSMC
TSM
|
+$779M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$3.39B |
| 2 |
Alibaba
BABA
|
+$1.33B |
| 3 |
AstraZeneca
AZN
|
+$1.12B |
| 4 |
Mastercard
MA
|
+$968M |
| 5 |
Goldman Sachs
GS
|
+$911M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 14.59% |
| 4 | Financials | 8.49% |
| 5 | Healthcare | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Healthcare Services Group
HCSG
$1.51B
| $8.05M | 0.01% |
286,578
-144,340
| -33% | -$3.49M |
|
427
ASML
ASML
$655B
| $8.04M | 0.01% |
16,483
+5,580
| +51% | +$2.35M |
|
|
INN
428
Summit Hotel Properties
INN
$724M
| $7.99M | 0.01% |
+886,731
| New | +$6.56M |
|
429
Constellium
CSTM
$3.88B
| $7.93M | 0.01% |
566,809
-22,777
| -4% | -$257K |
|
430
Wabtec
WAB
$49.9B
| $7.82M | 0.01% |
106,757
+681
| +0.6% | +$46.6K |
|
|
AEPPL
431
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $7.62M | 0.01% |
152,152
-661
| -0.4% | -$33.8K |
|
|
REGI
432
DELISTED
Renewable Energy Group, Inc.
REGI
| $7.51M | 0.01% |
106,094
-4,293
| -4% | -$262K |
|
433
KKR & Co
KKR
$92.8B
| $7.47M | 0.01% |
184,435
+45,327
| +33% | +$1.71M |
|
434
Maravai LifeSciences
MRVI
$922M
| $7.44M | 0.01% |
+265,386
| New | +$7.39M |
|
435
Arvinas
ARVN
$560M
| $7.39M | 0.01% |
+87,000
| New | +$3M |
|
436
Nutrien
NTR
$32B
| $7.09M | 0.01% |
147,272
-6,052
| -4% | -$268K |
|
|
PFPT
437
DELISTED
Proofpoint, Inc.
PFPT
| $6.96M | 0.01% |
51,058
-70,310
| -58% | -$7.71M |
|
438
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $6.95M | 0.01% |
109,533
-4,386
| -4% | -$224K |
|
|
ABCM
439
DELISTED
Abcam PLC
ABCM
| $6.56M | ﹤0.01% |
+304,563
| New | +$5.91M |
|
440
Nurix Therapeutics
NRIX
$2.62B
| $6.52M | ﹤0.01% |
198,251
-1,909
| -1% | -$63.3K |
|
441
Plains All American Pipeline
PAA
$16.6B
| $6.39M | ﹤0.01% |
775,104
-30,329
| -4% | -$231K |
|
442
Douglas Emmett
DEI
$1.93B
| $6.37M | ﹤0.01% |
218,334
-77,921
| -26% | -$2.21M |
|
|
DCP
443
DELISTED
DCP Midstream, LP
DCP
| $6.05M | ﹤0.01% |
+326,883
| New | +$5.14M |
|
444
Cadence Design Systems
CDNS
$93.2B
| $5.92M | ﹤0.01% |
43,385
-7,553
| -15% | -$886K |
|
445
New Fortress Energy
NFE
$98M
| $5.89M | ﹤0.01% |
109,908
-47,396
| -30% | -$2.17M |
|
446
Synopsys
SNPS
$77.7B
| $5.86M | ﹤0.01% |
22,594
-2,799
| -11% | -$646K |
|
447
iShares Russell 1000 Growth ETF
IWF
$127B
| $5.77M | ﹤0.01% |
95,672
+47,100
| +97% | +$2.68M |
|
448
C4 Therapeutics
CCCC
$402M
| $5.74M | ﹤0.01% |
+173,352
| New | +$5.03M |
|
449
HDFC Bank
HDB
$122B
| $5.63M | ﹤0.01% |
+155,932
| New | +$4.97M |
|
|
FOLD
450
PUT
DELISTED
Amicus Therapeutics
FOLD
| $5.54M | ﹤0.01% |
+240,000
| New | +$4.91M |
|
Similar funds
Jennison Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Jennison Associates held 734 positions worth $140B, up 13% from $124B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q4 2020 filing shows 114 new, 205 increased, 311 reduced and 95 closed positions. Its largest new stake was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M. The largest sale was Tesla, an estimated $3.39B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2020 buy was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M.
- Jennison Associates added most to Block Inc in Q4 2020, an estimated $1.67B increase.
- Jennison Associates's biggest Q4 2020 reduction was Tesla, cutting an estimated $3.39B.
- Jennison Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $181M.
- Jennison Associates's ten largest holdings make up 40% of its $140B portfolio in Q4 2020.
- Jennison Associates opened 114 new positions and closed 95 in Q4 2020.
- Jennison Associates's portfolio value rose 13% quarter-over-quarter to $140B.
Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.